Delivery Order SPE2DB22D1017-SPE2DB25FG8LN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 50 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $1,124.61. This non-set-aside competitive award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a $1,942.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for 90 tablets of Januvia 100 mg, a diabetes management medication. This non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,182.92 for 90 tablets of Januvia 100 mg on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Januvia 100 mg tablets in a quantity of 90 units, with a contract value of $2,182.92. The award utilizes firm fixed pricing with no set-aside designation, indicating competitive selection. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $7,401.38 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for Januvia 100 mg tablets (90-count units) on July 28, 2025, with a ceiling value of $2,218.86. This is a firm fixed price, non-set-aside contract with a completion date of July 29, 2025. The award was issued from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 50 mg tablets (90-count units) valued at $8,972.46 under a firm fixed-price contract structure. This non-set-aside award represents a child delivery order executed against AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $3,416.79 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Januvia 100 mg tablets (90-count units). This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with performance at the contractor's Conshohocken, Pennsylvania location and an ultimate completion date of July 24, 2025. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,683.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The order, which has an ultimate completion date of July 25, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and operates as a child contract under a larger vehicle. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,091.46 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement for pharmaceutical supply to federal medical systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order under its...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8LNDelivery Order
This delivery order, awarded July 29, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 90 tablets of Januvia 100 mg at a ceiling value of $1,637.19. The award represents a firm fixed-price, non-set-aside contract with a completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of medications and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical devices across multiple therapeutic domains. This Januvia order reflects the company's ongoing role in supporting military healthcare logistics and demonstrates the operational flexibility of the DLA's pharmaceutical prime vendor contracting approach, which manages deliveries ranging from small-value transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/29/25 |